Hormone replacement therapy, also called menopausal hormone therapy, can reduce bothersome menopause symptoms such as hot flashes, night sweats, vaginal dryness, painful sex, sleep disruption, and bone loss risk. The best option depends on your symptoms, uterus status, age, time since menopause, medical history, and personal risk factors.
Not sure where to start? Take the 3-min clinical quiz.
See if you qualify →What menopause symptoms can hormone replacement therapy help with?
Hormone replacement therapy can help several menopause symptoms, but it is not one treatment for every concern. The strongest everyday use is for vasomotor symptoms, especially hot flashes and night sweats, while vaginal symptoms may need local treatment; menopause usually occurs between ages 45 and 55 1.
Hot flashes and night sweats
Hot flashes and night sweats are called vasomotor symptoms. They happen when lower estrogen levels affect the brain’s temperature-control system, so the body reacts strongly to small temperature changes 1.
Systemic estrogen therapy, with progesterone when needed, is an established treatment for moderate to severe vasomotor symptoms 2. Side effects can include breast tenderness, nausea, bloating, headache, mood changes, and spotting, and clinicians also screen for blood clot, stroke, breast cancer, endometrial cancer, and cardiovascular risk 2.
Sleep problems, mood changes, and brain fog
Sleep often worsens because night sweats wake people up. Mood changes and brain fog can also appear during perimenopause and postmenopause, but they may also come from thyroid disease, depression, anxiety, sleep apnea, medication effects, or life stress 2.
HRT may improve sleep when it reduces night sweats, but it should not be sold as a reliable memory or dementia-prevention treatment. A 2024 meta-analysis of 34 randomized trials found mixed, timing- and formulation-dependent cognitive findings, not a broad cognitive benefit for all menopausal women 3.
Vaginal dryness, painful sex, and urinary symptoms
Lower estrogen can thin and dry vaginal and urinary tissues. This group of symptoms is often called genitourinary syndrome of menopause, and it can include vaginal dryness, burning, painful sex, urinary urgency, and repeat urinary discomfort 1.
Local vaginal estrogen products are often used when symptoms are mainly vaginal or urinary, while systemic HRT is considered when symptoms also include hot flashes or night sweats 2. A clinician should still review bleeding, breast cancer history, clotting history, and medication interactions before prescribing 2.
Bone loss and osteoporosis risk
Estrogen helps slow bone breakdown. After menopause, lower estrogen can speed bone loss and raise osteoporosis and fracture risk 1.
Menopausal hormone therapy can be used to prevent osteoporosis in selected patients, but it is not the only option and is not always the best fit. Bone-density history, fracture risk, kidney function, clotting risk, and other medications affect the choice 2.
Quick facts about HRT for menopause symptoms
HRT for menopause symptoms works by replacing or supplementing hormones that fall during the menopause transition. The decision is individualized, and the risk-benefit balance is different for a healthy 52-year-old with severe hot flashes than for someone starting later with complex medical history 4.
- Menopause means menstrual periods have permanently stopped; it usually happens between ages 45 and 55 1.
- Estrogen options include 17β-estradiol, conjugated equine estrogen, and other estrogen products; progesterone or another progestogen is added for many people with a uterus 2.
- Systemic hormone therapy reaches the whole body and is used for hot flashes and night sweats; local vaginal estrogen targets vaginal and urinary tissues 2.
- The Women’s Health Initiative showed that benefits and risks vary by age, timing, formulation, and health outcome; there is no single risk profile for every patient 5.
- FDA labeling changes for menopausal hormone therapy do not mean all risks are gone; risk information can still appear in Warnings and Precautions 6.
What is hormone replacement therapy, and how does it work?
Hormone replacement therapy is treatment with estrogen, and sometimes progesterone or another progestogen, to ease symptoms linked to lower ovarian hormone levels. The core decision is whether symptoms need whole-body treatment or a more targeted local approach, often reassessed over months of follow-up 2.
Why estrogen and progesterone fall during menopause
During perimenopause, ovulation becomes less regular. Estrogen and progesterone can swing up and down, then settle at lower levels after menopause 2.
Those hormone changes can affect blood vessels, temperature control, vaginal tissue, sleep, mood, and bone turnover. The same hormone shift can feel mild for one person and life-disrupting for another 1.
Systemic HRT versus local vaginal estrogen
Systemic HRT includes oral, transdermal, injectable, and some other forms that affect the whole body. It is usually considered when symptoms include hot flashes, night sweats, or broad menopause symptoms 2.
Local vaginal estrogen is different. It is aimed at vaginal and urinary tissue symptoms, so it may be considered when dryness, painful sex, or urinary discomfort are the main problems 2.
Estrogen-only therapy versus estrogen plus progesterone
Estrogen can thicken the uterine lining. In people with an intact uterus, adding progesterone or another progestogen helps reduce endometrial hyperplasia, which can lead to endometrial cancer 2.
If the uterus has been removed, estrogen-only therapy may be considered in some cases. Uterus status is one of the first safety questions a clinician asks before choosing a regimen 2.
Who may be a good candidate for HRT?
HRT candidacy is based on symptoms, age, time since menopause, uterus status, and medical risk. Many guidelines and reviews focus on people who are younger than 60 or within 10 years of menopause onset, while still requiring individual review 4.
Why age and time since menopause matter
The “timing hypothesis” means the benefit-risk balance may differ when HRT starts closer to menopause versus much later. Reviews of postmenopausal hormone therapy emphasize that age and time since menopause help shape cardiovascular and overall risk discussions 4.
This does not mean there is a single cutoff that applies to everyone. It means a clinician should weigh current symptoms against personal risks, current medications, and goals 4.
Why uterus status changes the treatment plan
If you have a uterus, systemic estrogen without adequate progesterone or progestogen can increase endometrial hyperplasia risk. That is why uterus status changes the treatment plan 2.
If you have had a hysterectomy, progesterone may not be needed for uterine protection. There may still be other reasons to use or avoid it, which should be reviewed clinically 2.
Medical history factors a clinician will review
A clinician will usually ask about breast cancer, endometrial cancer, unexplained vaginal bleeding, blood clots, stroke, heart disease, liver disease, migraine pattern, smoking, blood pressure, family history, and current medications 2.
They may also review when symptoms started, when your last period happened, and whether pregnancy is possible. Perimenopause can still include ovulation, so contraception may remain a separate need 2.
What are the benefits of HRT for menopause symptoms?
HRT benefits are strongest for bothersome vasomotor symptoms and selected menopause-related tissue changes. In clinical practice, the goal is symptom relief and risk reduction where appropriate, not disease prevention or anti-aging; individual results vary over weeks to months 2.
Evidence for hot flash and night sweat relief
Randomized evidence supports estrogen therapy, with or without a progestogen depending on uterus status, for vasomotor symptoms. StatPearls summarizes trial evidence showing oral estrogen with or without progestin reduced vasomotor symptoms compared with placebo 2.
Fair balance matters: the same treatment can cause spotting, breast tenderness, headache, nausea, bloating, or mood changes. It also requires screening for serious risks such as venous thromboembolism, stroke, cardiovascular disease, breast cancer, endometrial cancer, and dementia considerations 2.
Vaginal and sexual symptom relief
FDA consumer information lists vaginal dryness and painful sex among menopause symptoms that hormone therapies may help 1. Local vaginal options can be especially relevant when symptoms are limited to the vagina or urinary tract 2.
Clinical trials have also studied estriol for symptoms of natural or surgically induced menopause, but estriol is not the same as estradiol and should not be treated as interchangeable without clinician guidance 7.
Bone health benefits and limits
Menopausal hormone therapy can help prevent osteoporosis in selected patients 2. That does not mean it is the right osteoporosis plan for every person, especially if fracture risk is high or other risks make HRT a poor fit.
A clinician may consider calcium intake, vitamin D status, strength training, fall risk, bone-density testing, kidney function, and osteoporosis medications. HRT is one tool, not the whole bone-health plan 2.
3-min quiz
Considering HRT for menopause symptoms?
Chia offers HRT for Women, which includes Estradiol Oral + Progesterone IR, when a licensed U.S. provider decides it is clinically appropriate. Treatment starts with an online health questionnaire and clinician review; a prescription is not guaranteed. Compounded medications from 503A pharmacies are not FDA-approved.
What are the risks and side effects of HRT?
HRT risks depend on the hormone, route, dose, age, timing, and personal history. The Women’s Health Initiative and later analyses show that the balance of benefits and risks differs by therapy type and outcome, not by one simple yes-or-no rule 5.
Common side effects patients may notice
Common side effects can include breast tenderness, bloating, nausea, headache, mood changes, and irregular bleeding or spotting 2. Skin irritation may occur with patches or creams, and injections can cause injection-site reactions.
Bleeding after menopause, heavy bleeding, new breast changes, chest pain, shortness of breath, one-sided leg swelling, sudden severe headache, weakness, or vision changes should be reviewed urgently 2.
Blood clots, stroke, cardiovascular disease, breast cancer, dementia, and endometrial cancer considerations
The Women’s Health Initiative randomized trials found that health outcomes varied during treatment and after stopping, including effects on cardiovascular events, cancers, fractures, and overall risk-benefit balance 5. A 2025 secondary WHI analysis focused on women with vasomotor symptoms also supports careful, individualized cardiovascular risk review 8.
The FDA has requested removal of certain broad boxed-warning statements about cardiovascular disease, breast cancer, and probable dementia from menopausal hormone therapy labels, while not seeking removal of the boxed warning for endometrial cancer for systemic estrogen-alone products 6. This labeling change does not mean risks are gone; risk details may remain in Warnings and Precautions 1.
How route, dose, age, and timing may affect risk
Route can matter. Oral, transdermal, vaginal, injectable, and other forms differ in how they enter the bloodstream and how the liver processes them 2.
Clinicians often discuss the lowest effective dose concept, follow-up timing, and whether symptoms still justify treatment. This is shared decision-making, not a one-time prescription decision 4.
What types and forms of HRT are available?
HRT forms include pills, patches, gels, sprays, creams, injections, rings, and vaginal products. Some products are FDA-approved, while compounded options are prepared by licensed pharmacies for a specific prescription; these categories are not the same and should be discussed before starting treatment 1.
Pills, patches, creams, injections, gels, sprays, rings, and vaginal products
| Form | Common use | Key trade-off |
|---|---|---|
| Oral tablets or capsules | Systemic symptoms like hot flashes and night sweats | Easy to take, but liver first-pass metabolism may matter for some risks |
| Transdermal patch, gel, spray, or cream | Systemic symptoms | Avoids first-pass liver metabolism, but skin irritation can occur |
| Injection | Systemic treatment in selected plans | Less frequent administration for some plans, but requires comfort with injections |
| Vaginal cream, tablet, ring, or insert | Vaginal dryness, painful sex, urinary symptoms | More targeted to local tissues, but not meant for whole-body hot flash control |
FDA-approved products versus compounded medications
FDA-approved menopausal hormone therapies have FDA-reviewed labeling for approved uses and risks 1. Compounded estradiol via a 503A pharmacy and compounded progesterone via a 503A pharmacy are made for an individual prescription, but compounded medications are not FDA-approved.
The practical safety line is licensed care: a real medical evaluation, a state-licensed 503A pharmacy, and follow-up. Avoid no-prescription hormone products or “research” vendors that bypass clinician review.
Bioidentical hormones: what the term means and what it does not prove
“Bioidentical” usually means the hormone has the same chemical structure as a hormone made by the body, such as 17β-estradiol or micronized progesterone. It does not automatically prove that a product is safer, more effective, or right for you 2.
For a deeper plain-English review, see our guide to bioidentical hormone replacement therapy. If side effects are your main concern, our overview of estrogen and progesterone side effects may help you prepare for a clinician visit.
What are natural and non-hormonal alternatives to HRT?
Non-hormonal menopause care can help many people, especially when symptoms are mild or HRT is not a good fit. The safest plan often starts with low-risk steps, then considers prescription options if symptoms remain disruptive for daily life 1.
Lifestyle steps with the best safety profile
Helpful low-risk steps include keeping the bedroom cool, dressing in layers, limiting alcohol if it triggers symptoms, stopping smoking, regular movement, strength training, and sleep routines. These steps may not fully control severe hot flashes, but they support overall health and have a strong safety profile 1.
FDA-approved non-hormonal options for hot flashes
Some non-hormonal prescription medications are used for vasomotor symptoms, including certain antidepressants and newer hot-flash medicines. Choice depends on depression history, sleep needs, blood pressure, liver health, other medicines, and side effects 1.
Vaginal moisturizers, lubricants, and pelvic-floor care
For vaginal dryness or painful sex, moisturizers and lubricants are often a first step. Pelvic-floor physical therapy may help when pain, pelvic tension, bladder symptoms, or painful penetration are part of the picture.
When supplements are risky or unsupported
Supplements marketed for menopause vary widely in quality and evidence. Some can interact with blood thinners, antidepressants, seizure medicines, or cancer therapies, so it is important to tell your clinician what you take 2.
For a broader symptom-by-symptom view, read our guide to treatments for menopause symptoms and our overview of HRT for menopause.
Which menopause option fits which person?
Menopause treatment choice depends on the symptom pattern. A person with severe night sweats may need a different plan than someone with only vaginal dryness, and the safest next step can change after follow-up 1.
| Your situation | Sensible next step to discuss | Important trade-off |
|---|---|---|
| Hot flashes and night sweats are the main issue | Systemic HRT or non-hormonal prescription options | HRT may be effective, but clot, stroke, cancer, cardiovascular, and bleeding risks need review |
| Vaginal dryness, painful sex, or urinary discomfort without hot flashes | Vaginal moisturizers, lubricants, pelvic-floor care, or local vaginal estrogen | Local therapy may not treat whole-body symptoms |
| You have a uterus and are considering systemic estrogen | Estrogen plus progesterone or another progestogen | Progesterone helps protect the uterine lining but can cause side effects |
| You had a hysterectomy | Estrogen-only therapy may be considered in some cases | Other risks still matter, including clot, stroke, breast health, and cardiovascular history |
| You have a history of breast cancer, blood clots, stroke, unexplained bleeding, or high-risk heart disease | Specialist-guided review before any hormone therapy | HRT may not be appropriate, and non-hormonal options may be safer |
Hormone therapy for menopause symptoms at Chia
Chia hormone therapy is a clinician-reviewed online option for some people with menopause symptoms. We offer HRT through licensed U.S. provider evaluation, provider-guided dosing, state-licensed 503A pharmacy compounding, and home delivery when treatment is appropriate; a prescription is not guaranteed.
Chia HRT for Women: Estradiol Oral + Progesterone IR
Chia’s HRT for Women protocol includes Estradiol Oral + Progesterone IR and currently starts at $119/mo. It is designed for clinician-reviewed menopause care when a licensed provider decides systemic hormone therapy fits the patient’s symptoms and risk profile.
Chia estradiol options: cream, injection, and transdermal patch
Chia also offers estradiol as cream, injection, and transdermal patch; estradiol injection plans currently start at $109/mo. Estradiol is a form of estrogen used in menopause care, but route choice depends on medical history, goals, side effects, and clinician judgment 2.
Chia progesterone options: cream and injection
Chia offers progesterone as cream and injection; progesterone injection plans currently start at $109/mo. Progesterone is often part of systemic HRT when the uterus is present, because it helps reduce endometrial hyperplasia risk from estrogen exposure 2.
| Chia option | Forms listed in Chia’s catalog | Current starting price | Where it may fit |
|---|---|---|---|
| HRT for Women | Estradiol Oral + Progesterone IR | From $119/mo | A combined menopause HRT protocol after clinician review |
| Estradiol | Cream, injection, transdermal patch | Injection from $109/mo | Estrogen therapy options when clinically appropriate |
| Progesterone | Cream, injection | Injection from $109/mo | Often considered with systemic estrogen when the uterus is present |
How online clinician review, eligibility, prescribing, and shipping work
At Chia, care starts with a short online health questionnaire. A licensed U.S. provider reviews symptoms, uterus status, age, time since menopause, medications, personal and family history, and risk factors before deciding whether prescribing is appropriate.
If prescribed, medication is compounded by a state-licensed U.S. 503A pharmacy and shipped to your door. Dosing is provider-guided and adjusted over time, and patients can message the care team through the portal between visits.
When Chia may not be the right path
Chia may not be the right path if you have unexplained postmenopausal bleeding, active or recent hormone-sensitive cancer, a history of blood clots or stroke, unstable cardiovascular disease, severe liver disease, or symptoms that need in-person urgent care. In those cases, in-person evaluation or specialist care may be safer.
How should you talk with a clinician about HRT?
Shared decision-making means you and a clinician weigh symptom relief against risks, preferences, and follow-up plans. Bring a clear symptom timeline, health history, and questions about route and reassessment before choosing a first plan 4.
Symptoms and goals to bring up
Tell your clinician which symptoms bother you most: hot flashes, night sweats, sleep disruption, mood changes, vaginal dryness, painful sex, urinary symptoms, or bone health worries. Include how often they happen and how they affect work, relationships, exercise, and sleep.
Personal and family history to disclose
Share any history of breast cancer, uterine cancer, ovarian cancer, blood clots, stroke, heart disease, high blood pressure, migraine with aura, liver disease, smoking, abnormal bleeding, and close family history. Bring a medication and supplement list 2.
Questions to ask about dose, route, follow-up, and stopping
- Which symptom are we trying to improve first?
- Do I need progesterone because I have a uterus?
- Which route fits my medical history: oral, patch, cream, injection, or local vaginal treatment?
- What side effects should I expect, and which symptoms mean I should contact you quickly?
- When will we reassess whether this is helping?
- How will we decide whether to continue, adjust, or stop later?
What changes over time with HRT?
HRT follow-up is part of safe care because symptoms, side effects, and risk factors can change. Many people reassess benefit and tolerability after the first few months, then revisit the plan regularly 2.
Early on, a clinician may watch for nausea, breast tenderness, bloating, headache, mood changes, skin irritation, or bleeding. If symptoms improve but side effects are a problem, route or formulation may be reviewed 2.
Over time, the discussion shifts to whether symptoms still justify treatment, whether new risk factors have appeared, and whether a different route or non-hormonal plan would be better. HRT is not meant to be set and forgotten.
When should you get help now?
Menopause symptoms are common, but some symptoms need prompt care. Get urgent help for chest pain, shortness of breath, one-sided weakness, sudden severe headache, vision changes, coughing blood, or one-sided leg swelling; these can signal serious events such as a clot or stroke 2.
Call a clinician promptly for bleeding after menopause, heavy or unusual bleeding, new breast changes, pelvic pain, severe depression, or symptoms that interfere with basic daily life. Do not start or restart hormones without a medical review.
3-min quiz
Start with a clinician-reviewed menopause visit
If menopause symptoms are disrupting sleep, sex, mood, or daily life, you can start Chia’s online eligibility visit. A licensed U.S. provider reviews your history and prescribes only when clinically appropriate; a prescription is not guaranteed. Learn more about HRT for Women, estradiol, and progesterone. Compounded medications from 503A pharmacies are not FDA-approved.
FAQ about HRT for menopause symptoms
There is no single sign that means someone needs HRT. It may be worth discussing when hot flashes, night sweats, vaginal dryness, painful sex, sleep disruption, or bone-loss concerns are affecting quality of life and low-risk steps are not enough.
There is no universal age cutoff, but age and time since menopause matter. Many risk-benefit discussions are more favorable for people under 60 or within 10 years of menopause, while later starts need more careful review.
If you have a uterus and use systemic estrogen, progesterone or another progestogen is usually used to help protect the uterine lining. If you had a hysterectomy, progesterone may not be needed for that purpose.
Duration is individualized. A clinician should reassess symptoms, side effects, risks, and preferences over time, then decide with you whether to continue, adjust, or stop.
HRT is not a weight-loss treatment. It may help some menopause symptoms that affect sleep or quality of life, but weight change has many drivers, including muscle loss, activity, sleep, medications, thyroid disease, and nutrition.
No. Compounded HRT is prepared for an individual prescription by a compounding pharmacy, but compounded medications are not FDA-approved and do not have FDA-evaluated outcomes data.
Yes, online HRT can be safe when it includes a real medical history review by a licensed clinician, appropriate screening, a legitimate prescription, a state-licensed pharmacy, and follow-up. Avoid no-prescription hormone sellers.
No. HRT should not be used as a proven way to prevent dementia, heart disease, cancer, or aging-related disease. Its main role is symptom management and selected bone-health use after clinical review.
References
- 1.U.S. Food and Drug Administration. Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms. FDA Consumer Update, 2026.
- 2.Ali AT, Penny CB, Paiker JE, et al. Hormone Replacement Therapy. StatPearls. NCBI Bookshelf, 2026.
- 3.Wang Y, Lin Y, Chen X, et al. Systematic review and meta-analysis of the effects of menopausal hormone therapy on cognitive function. Frontiers in Endocrinology, 2024.
- 4.Genazzani AR, Monteleone P, Giannini A, et al. Hormone therapy in the postmenopausal years: considering benefits and risks in clinical practice. Human Reproduction Update, 2021.
- 5.Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA, 2013.
- 6.U.S. Food and Drug Administration. HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy. FDA News Release, 2025.
- 7.Takahashi K, Okada M, Ozaki T, et al. Safety and efficacy of oestriol for symptoms of natural or surgically induced menopause. Human Reproduction, 2000.
- 8.Rossouw JE, Aragaki AK, Manson JE, et al. Menopausal Hormone Therapy and Cardiovascular Diseases in Women With Vasomotor Symptoms: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trials. JAMA Internal Medicine, 2025.
- 9.Moyer AM, de Andrade M, Faubion SS, et al. SLCO1B1 genetic variation and hormone therapy in menopausal women. Menopause, 2018.
- 10.Gambrell RD Jr. The menopause. Investigative Radiology, 1986.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
Find what fits your body and your goals.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
